XieLi passed the PMDA inspection on Irinotecan HCl again

Japan PMDA proceeded the site inspection on April 12-14, 2016 for Xieli’s API “ Irinotecan HCl”. The results show that Xieli’s product  Irinotecan HCl meets PMDA's requirements on GMP management.